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454a Tuesday, February 5, 2013activation of the voltage sensors in the fourth transmembrane segment (S4) is
transduced into pore opening via coupling of the S4-S5 linker to the C-terminal
S6 segment. In TRPA1, the gain-of-function mutation N855S located in the S4-
S5 region has been associated with familial episodic pain syndrome. In an at-
tempt to elucidate the role of the S4-S5 linker and its putative interaction(s)
with S6 or the first C-terminal helix in the voltage-dependent gating of
TRPA1, we used site-directed mutagenesis, whole-cell electrophysiology,
single-channel recording, and molecular dynamics simulations. The charge-
reversal mutations K868E and K969E resulted in a decrease in the rectification
index compared to wild-type TRPA1 channels, and a virtually voltage-
independent conductance-voltage (G-V) relationship. This effect was also ob-
served in the adjacent charge-neutralizing mutant H970A, but was less pro-
nounced in charge- reversal H970D. These results indicate that positively
charged residues in the S4-S5 linker and the helix adjacent to the C-terminal
S6 segment play a vital role in the voltage-dependent gating of TRPA1.
This work was supported by Czech Science Foundation Grant 305/09/0081, Re-
search Project Fund of the Academy of Sciences of the Czech Republic Grant
RVO:67985823, and Ministry of Education, Youth and Sports of the Czech Re-
public Grants OP VK CZ.1.07/2.3.00/30.0025, MSM0021620835, SVV-2010-
261 304, and GAUK 426311.
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Human skin is constantly exposed to solar ultraviolet radiation (UVR), the most
prevalent environmental carcinogen. Humans have the unique ability among
mammals to respond to UVR by increasing their skin pigmentation, a protective
process driven by melanin synthesis in epidermal melanocytes. However, the
mechanism used by melanocytes to detect and respond to UVR is not well un-
derstood. Here we report that transient receptor potential A1 (TRPA1) ion
channels expressed in human melanocytes are activated by UVR and mediate
early melanin synthesis. We show that in human epidermal melanocytes
(HEMs) physiological doses of UVR activate a retinal-dependent current me-
diated by TRPA1. The UVR photocurrent density was reduced by TRPA1 an-
tagonists and abolished in HEMs expressing TRPA1-targeted miRNA. The
TRPA1 photocurrent is UVA specific and requires G protein signaling, provid-
ing the first evidence for TRPA1 function in mammalian phototransduction. In
HEMs, TRPA1 activation contributes to UVR-induced calcium responses to
mediate downstream cellular effects. Remarkably, the UVR-induced and
retinal-dependent early increase in cellular melanin content was significantly
reduced in HEMs treated with TRPA1 antagonists and abolished in HEMs ex-
pressing TRPA1-targeted miRNA, suggesting that TRPA1 is required for early
melanin synthesis. Our results show that TRPA1 is essential for a novel extra-
ocular phototransduction pathway in human melanocytes that is activated by
physiological doses of UVR and results in early melanin synthesis.
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Canonical transient receptor potential channels (TRPC3/6) are mechano-
sensitive, receptor- and store-operated channels that mediate Ca2þ/Naþ influx
into cells. TRPC3/6 are implicated in the regulation of vascular tone, cell
growth, proliferation and pathological hypertrophy. Potent and selective small
molecule TRPC3/6 agonist and antagonist tools had been lacking to study the
functions of TRPC3/6. We report here potent, small molecule agonist
(GSK1702934A) and antagonists (GSK417651A and GSK2293017A) of
TRPC3/6. Whole-cell patch-clamp experiments demonstrated that
GSK1702934A activated TRPC3 and TRPC6 current in HEK293 cells trans-
duced with recombinant human TRPC3 or TRPC6 with an EC50 of ~
0.08 mM and 0.44 mM, respectively. GSK417651A inhibited both TRPC3
and TRPC6 current with IC50s of ~ 0.04 mM. A more potent TRPC3/6 antago-
nist GSK2293017A exhibited an IC50 of ~ 0.01 mM. GSK417651A was likely
acting on TRPC3/6 from the extracellular side, because dialyzing the cells with
10 mM GSK417651A in the pipette solution did not prevent the activation of
TRPC6. In the rat cardiomyocyte like cell line H9C2, GSK1702934A
(1 mM) activated TRPC6-like current which was completely blocked by
GSK417651A (1 mM). TRPC3/6 activator GSK1702934A (1 mM) transientlyincreased the perfusion pressure of isolated rat heart retrogradely perfused
via aortic cannulation. This effect was completely eliminated by pretreatment
with the TRPC3/6 blocker GSK2293017A (1 mM). IV bolus of GSK1702934A
(0.3 ~ 3 mg/kg) transiently increased blood pressure by 15 ~ 35 mmHg in con-
scious Sprague Dawley rats. This blood pressure effect was dose-dependently
inhibited by pretreatment of GSK2293017A (2.5 ~ 250 mg/kg/min infusion for
30 min) with complete inhibition occurring at a free plasma concentration of
0.81 mM. Therefore, these small molecule agonist and antagonists could be use-
ful tools to help understand the characteristics and functions of TRPC3/6 in tis-
sues and animals.
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Subfamily of human expressed TRPC channels (TRPC3/6/7) are activated by
‘diacylglycerol’ (DAG), a phospholipase C (PLC) hydrolyzed product of phos-
phatidylinositol 4,5-bisphosphate [PI(4,5)P2] (Hofmann et al., 1999, Nature).
In contrary, we have recently reported that the depletion of PI(4,5)P2 by-
itself act as a potent negative regulator to all these channels even in the pres-
ence of DAG (Imai et al., 2012, J. of Physiol.). Stimulation upon the vasocon-
strictile receptors coupled with PLC theoretically causes inseparable bimodal
effect to these TRPC channels, i.e. activation and inhibition by DAG produc-
tion and coincident PI(4,5)P2 reduction or depletion which is corresponding
to the strength of PLC activities. Here, to elucidate such self-limiting regulatory
function coupled to PI(4,5)P2-DAG signal, we simultaneously measure
TRPC6/7 currents in the whole-cell configuration and PI(4,5)P2 dynamics by
FRET using PI(4,5)P2 binding PH-domain sensor proteins in the various
strength of muscarinic- or vasopressin-receptor stimulation. Our simultaneous
detection approach reveals good kinetics correlation between TRPC activation/
fast-inactivation and PI(4,5)P2 depletion. Furthermore, a simple self-limiting
regulation model wherein experimentally determined PI(4,5)P2 binding con-
stants incorporated aware an emergence of fast recovery of PI(4,5)P2 to pro-
duce slow inactivation (plateau phase) of TRPC currents. We find that such
model implicated PI(4,5)P2 enhancement can be reproduced after the fast
PI(4,5)P2 depletion under the robust agonist stimulation by the local FRET
measurement near the channels. Hence, these data indicates that self-limiting
regulation coupled to PI(4,5)P2-DAG signal is the pivotal mechanism to under-
stand the receptor-PLC mediated TRPC3/6/7 channels activity.
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Canonical transient receptor potential (TRPC) channels have six transmem-
brane (6-TM) domains and are Ca2þ-permeable and non-selective cation chan-
nels. It is generally speculated that TRPC channels are activated by stimulation
of Gq-PLC-coupled receptors and oxidation. Activator of G-protein signaling1
(AGS1 or RASD1), the ras-related protein, interacts with Gi/Go and activates
heterotrimeric G-protein signaling systems independent of G-protein-coupled
receptor (GPCR). It is previously reported that AGS1 is related to GIRK chan-
nel and Ca2þ channel. However it is unknown whether AGS1 is associated with
TRPC channels. We assumed that AGS1 might regulate TRPC4 channel, since
AGS1 interacts with Gi/Go and TRPC4 is activated by Gi/o subunits. Here, we
measured whole cell current of TRPC4/5 after the co-expression of TRPC4 or
TRPC5 with constitutively active form of small GTPases in HEK293 cells.
AGS1 (CA) mutant (Q to L) activated TRPC4 (38.8 5 7.2 pA/pF) without
GTPgS and independently of GPCR. Pertussis toxin (PTX), Gai specific inhib-
itor, blocked RASD1-activated TRPC4 current (3.451.6 pA/pF). When co-
expressed with dominant negative Gai protein subtype, TRPC4 activation by
RASD1 was completely inhibited. With previous report that TRPC4 are acti-
vated primarily by selective Gai subunits rather than Gaq, these results suggest
that AGS1 activates TRPC4 channel through modulating Gai subunits and
AGS1 is a new activator for TRPC4 channel.
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The Transient Receptor Potential Canonical 4 (TRPC4) channel is a Ca2þ-per-
meable, non-selective cation channel in mammalian cells and mediates
Tuesday, February 5, 2013 455aa number of cellular functions. Many studies show that TRPC channels are ac-
tivated by stimulation of Gaq-PLC-coupled receptors. However, our previous
study showed that the TRPC4 current was inhibited by a constitutively active
form of Gaq(Gaq
Q209L). It may have caused a shortage of phosphoinositide
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) because Gaq
Q209L would
have persistently activated PLCb. Therefore, we used an inducible system to
regulate PI(4,5)P2 specifically and acutely. The TRPC4b current was reduced
by inducible Gaq
Q209L but not by the mutants whose binding ability to PLCb
is impaired. If the aforementioned phenomenon resulted from desensitization
of TRPC4 by protein kinase C (PKC), the current of TRPC4b (T877A) mutant
which is not phosphorylated by PKC would not be inhibited by co-expression
of a Gaq
Q209L. However, we detected the inhibitory action of Gaq
Q209L. Deple-
tion of PI(4,5)P2 using the inositol polyphosphate 5-phosphatase (Inp54p) in-
ducible system led to an irreversible inhibition of TRPC4 currents after
application of rapamycin to HEK293 cells co-expressing TRPC4 with
Inp54p. On the other hand, phosphatidylinositol 4-phosphate 5-kinase
(PIP5K) inducible system did not activate the initial gating of TRPC4b.
Even in the case of Gai2-activated TRPC4b currents, the acute depletion of
PI(4,5)P2 led to reduced TRPC4b currents. Therefore, we suggested that
PI(4,5)P2 is not the activator for TRPC4 activation but it is still necessary for
regulating TRPC4 activation. Especially, TRPC4 desensitization might be a re-
sult of hydrolysis of PI(4,5)P2 since TRPC4 desensitization through muscarinic
receptor 3 which activates Gaq-PLC pathway disappeared by adding PI(4,5)P2
and nonhydrolysis PI(4,5)P2. These findings indicate an essential role of PI(4,5)
P2 for maintaining the activity of TRPC4b.
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Mechanical forces are efficiently converted into cellular signals to initiate
structural and functional remodeling of cardiac myocytes. Molecular mecha-
nisms underlying cardiac mechanotransduction are still barely understood. Nu-
clear Factor of Activated T-cells (NFAT) is an important calcium-responsive
transcription factor and a key player in cardiac remodeling processes. In this
study, we investigated the involvement of Ca2þ signaling molecules as a link
between mechanical stretch and NFAT translocation in HL-1 atrial myocytes.
We specifically focused on the potential role of receptor-operated and/or store-
operated Ca2þ permeable channels of the TRPCs (classical transient receptor
potential) and the Orai family. Populations of HL-1 cells overexpressing
GFP-NFAT were exposed to a single-stretch by 20% for 20 minutes on com-
mercially available silicon membranes and NFAT localization was then ana-
lyzed by fluorescence microscopy. Results revealed that stretched HL-1 cells
significantly increased NFAT nuclear translocation when compared to un-
stretched cells. Similar NFAT activation was obtained when HL-1 cells were
stimulated by either endothelin-1 (100 nM) or thapsigargin (1mM) in the ab-
sence of a stretch stimulus. These results demonstrate that similar levels of
NFAT activation are induced in HL-1 cells by either mechanical stress, cell ac-
tivation via Gq-coupled receptors or depletion of internal Ca2þ stores. HL-1
cells were found to express several TRPC isoforms that might contribute to me-
chanotransduction. Our data suggest a linkage between mechanical stretch and
cardiac remodeling involving Ca2þ entry and NFAT activation.
This work is funded by FWF (Austrian research fund) projects P21925-B19,
P22565-B18 and the DK Metabolic and Cardiovascular Disease grant
W1226-B18.
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TRPM2 is a non-selective Ca2þ permeable cation channel, expressed abun-
dantly in brain, immune cells, and pancreatic b-cells. Under physiological con-
ditions it might play a role in glucose-induced insulin secretion, and in the
immune response. Besides, it enhances the sensitivity of cells toward oxidative
stress induced damage. Thus, under pathological conditions, TRPM2 is respon-
sible for neuronal cell death during ischemia/reperfusion in the brain.
The TRPM2 channel is co-activated by intracellular Ca2þ and ADP-ribose
(ADPR). ADPR binds to the C-terminal NUDT9-H domain, while the Ca2þ
binding sites have not yet been identified. Intriguingly, when expressed in iso-
lation, the NUDT9-H domain functions as an active ADPR hydrolase whichbreaks ADPR into AMP and ribose-5-phosphate. In a previous study we
showed that Ca2þ dependent gating is well described by the Monod-Wyman-
Changeux model. However, little is known about the mechanism by which
binding, and possibly hydrolysis, of ADPR is coupled to channel gating.
Steady-state single-channel kinetic analysis could be very useful for addressing
such details. However, wild-type TRPM2 channels are not amenable to such
studies, because they inactivate irreversibly shortly after patch excision, pre-
cluding collection of sufficient numbers of gating events. Recently, we have
identified that inactivation is caused by a conformational change of the selec-
tivity filter, and can be completely prevented by a triple mutation in this region.
This pore mutant TRPM2 channel (T5L), which mimics the filter sequence of
TRPM5, retains unabated maximal activity for over 1 hour. Although the mu-
tations result in altered permeation properties, ADPR- and Ca2þ-dependent gat-
ing remains intact.
Presently, we are investigating the ADPR-dependent gating mechanism of this
mutant channel by steady-state single-channel kinetic analysis. Measurements
are underway.
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TRPM2 channels are expressed in the heart and vasculature. To elucidate the
function of TRPM2, we generated a global TRPM2-KO mouse. To evaluate
whether TRPM2 channels were functional in the heart, we activated TRPM2
channels with H2O2 and demonstrated that Ca
2þ influx was dependent on ex-
tracellular Ca2þ and significantly higher in WT compared to TRPM2-KO my-
ocytes. We then examined the effects of TRPM2 channels on cardiac function,
both at rest and after ischemia-reperfusion (I/R) injury. At rest, there were no
differences in LV mass, heart rate, fractional shortening (FS) and þdP/dt be-
tween WT and TRPM2-KO hearts. At 2-3 days post-I/R injury, despite similar
areas-at-risk and infarct sizes, TRPM2-KO hearts had lower FS and þdP/dt
when compared to WT hearts. Compared to WT I/R myocytes, expression of
Naþ/Ca2þ exchanger (NCX1) and NCX1 current were increased, and action
potential duration was prolonged in TRPM2-KO I/R myocytes. After 2 h of
hypoxia followed by 30 min of reoxygenation to simulate I/R in vitro, levels
of reactive oxygen species (ROS) were significantly higher in TRPM2-KO
when compared to WT myocytes. Oxygen radical scavenging enzymes
(SOD1 and SOD2) and their upstream regulators (FoxO1, FoxO3a and HIF-1a)
were lower while NADPH oxidase (Nox2) was higher in TRPM2-KO I/R
hearts. We conclude that TRPM2 channels protected hearts from I/R injury
by enhancing expression of oxygen radical scavenging enzymes, thereby reduc-
ing oxidative stress associated with ischemia-reperfusion.
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2-APB is a widely used chemical compound in ion channel research. It in-
hibits numerous channels that include inositol 1,4,5-trisphosphate receptors,
store-operated calcium channels, connexins and TRP family cation channels
TRPC3, TRPC5, TRPC6, TRPM2, TRPM3 and TRPM7. Native and over-
expressed TRPM7 channels are inhibited by 2-APB with IC50-s in the
70-170 mM range. A characteristic of TRPM7 channels is their inhibition
by intracellular Mg2þ and acidic pH. using patch-clamp electrophysiology,
we recorded native TRPM7 channel activity in Jurkat T lymphocytes and
tested 2-APB at 10-300 mM for its ability to inhibit TRPM7 currents. When
internal HEPES buffer concentration was low (1 mM), 100-300 mM 2-APB
inhibited 60-70% of TRPM7 current with a slow time course. This inhibition
was voltage-independent and reversible. Increasing the pH buffering capacity
of internal solution to 140 mM HEPES abolished the inhibitory 2-APB effect.
Simply making the internal recording solution alkaline, greatly diminished 2-
APB inhibition. using single-cell pHi imaging with the fluorescent pH indica-
tor BCECF, we found that at concentrations of 100 mM and higher, 2-APB
potently acidifies the cytoplasm. A similar 2-APB-induced acidification was
also observed in HEK293 cells, often used for TRPM7 channel overexpres-
sion. In contrast to 2-APB, its analog 2,2-diphenyltetrahydrofuran (DPTHF)
did not produce cytosolic acidification, when applied at concentrations of
150-300 mM. We also found that Kv1.3 channels expressed in Jurkat
T cells are modulated by 2-APB: the apparent voltage dependence of these
